Many team members at Unicorn Nest are Ukrainians affected by Russian aggression. We do our best to solve any issues and answer your questions in the shortest possible time frames but some delays are possible.

Proxima Ventures Ltd

Founders Chaim Venezia Uri Ra'anan Zvi Margalit

Overview

Investments

Unlock datapoints

Portfolio analytics

Team

News & Media

Add fund to favorites
info
Save this fund for later to form your own custom list of funds
This summary is composed by our algorithm based on the analysis of the deals. If you think that some of this information is not accurate, please let us know about it and provide any supporting evidences if possible. Such cases will be analyzed by our ML-algorithm and implemented in our database, which will improve this summary.

Need help with fundraising?

We offer an assisted fundraising option for startups

Learn more
Total investments 21
Average round size
info
The average size of a deal this fund participated in
$15M
Portfolio companies 15
Lead investments 6
Follow on index
info
How often the fund supports its portfolio startups at next rounds
0.29
Exits 1
Key employees 4
Stages of investment
Early Stage Venture
Seed

Areas of investment

  • Biotechnology
  • Therapeutics
  • Health Care
  • Medical
  • Psychology
Summary

The company was established in Asia in Israel. The leading representative office of defined VC is situated in the Tel Aviv.

The fund has specific favorite in a number of founders of portfolio startups. For fund there is no match between the location of its establishment and the land of its numerous investments - China. Among the most popular portfolio startups of the fund, we may highlight HiFiBiO, Cygnus Biosciences, Soluto. Among the most successful fund investment fields, there are Advertising, Health Care. Besides, a startup requires to be at the age of 2-3 years to receive the investment from the fund.

The common things for fund are deals in the range of 5 - 10 millions dollars. Speaking about the real fund results, this VC is 10 percentage points more often commits exit comparing to other organizations. The important activity for fund was in 2018. Despite it in 2019 the fund had an activity. The fund is constantly included in less than 2 deals per year. The higher amount of exits for fund were in 2013. Comparing to the other companies, this Proxima Ventures Ltd performs on 19 percentage points less the average number of lead investments.

The usual cause for the fund is to invest in rounds with 3-4 partakers. Despite the Proxima Ventures Ltd, startups are often financed by Founder Collective, Yueyin Venture Capital, Nest.Bio Ventures. The meaningful sponsors for the fund in investment in the same round are Yueyin Venture Capital, Giza Venture Capital, Founder Collective. In the next rounds fund is usually obtained by Giza Venture Capital, Bessemer Venture Partners, initial.vc.

The fund was created by Chaim Venezia, Uri Ra'anan, Zvi Margalit. Besides them, we counted 4 critical employees of this fund in our database.

Read more

Related Funds

Funds investing in previous rounds
These funds often invest in the rounds preceeding the rounds of Proxima Ventures Ltd:
Typical Co-investors
Proxima Ventures Ltd is more likely to invest in rounds together with the following funds:
Funds investing in following rounds
These funds have a tendency to invest in the following rounds after Proxima Ventures Ltd:
There are no funds here. If we find new data, we will add it here.

Funds with similar focus

Funds from Israel
Funds with similar focus located in Israel:
Funds with the same geo focus
Funds with similar geography of portfolio companies:
Funds doing lead investments
Funds with similar focus acting as lead investors:

Look at other 50 related and similar funds Collapse list
Fund NameLocation
AI Music England, Kent, United Kingdom
Brockhaus Private Equity Frankfurt, Germany, Hessen
Caton Technology (Asia) China, Hong Kong, Hong Kong Island
Fibrotic Ventures Atlanta, Georgia, United States
Honest Ventures -
MCI Capital SA Mazowieckie, Poland, Warsaw
NEC Capital Solutions Chiyoda, Japan
Optim Japan, Tokyo
Purity Star -
SGRF Masqat, Muscat, Oman
Sniper Investments Belgium, Limburg, Mechelen-bovelingen
Sumin Investment -
The Raine Group New York, New York, United States
Topspin Fund -
Weatherford International Baar, Switzerland, Zug
Zero2IPO Capital Beijing, Beijing, China

Notable deals

CompanyIndustryRound SizeDateInvestorsLocation

VerImmune

Biotechnology
Therapeutics
$4M23 Sep 2024 Baltimore, Maryland, United States

Rapafusyn Pharmaceuticals

$28M20 Jun 2024 Baltimore, Maryland, United States

VerImmune

Biotechnology
Therapeutics
$3M20 Sep 2023 Baltimore, Maryland, United States

Immune-Onc Therapeutics

Biopharma
Biotechnology
Health Care
Medical
Therapeutics
$25M05 Jan 2023 Palo Alto, California, United States

VerImmune

Biotechnology
Therapeutics
$2M27 Jul 2022 Baltimore, Maryland, United States

Yidianling

Psychology
$30M22 Dec 2021 Shanghai, China

Great Bay Bio

Biopharma
Biotechnology
Life Science
$10M01 Dec 2021 Hong Kong Island, Hong Kong, China

Bioelectronica

Biotechnology
Electronics
Health Diagnostics
08 Feb 2021 Reno, Nevada, United States

Singlera Genomics

Biotechnology
Genetics
Health Care
Health Diagnostics
Medical
$150M15 Dec 2020 San Diego, California, United States

Review

  • No reviews are submitted yet.
Do you want more?
We provide dozens of additional datapoints about this fund.
Sign up and get access to full fund profile and advanced analysis.
Full team
Industries heatmap
Stages heatmap
Georgaphy breakdown
Coinvestors
Portfolio analysis
Performance indexes
Latest highlights
Unlock all data
Do you represent Proxima Ventures Ltd?
Get access to manage this page
Get in touch
Found incorrect info? Let us know!
Total investments 21
Average round size 15M
Peak activity year 2018
Lead investments 6
Follow on index 0.29
Exits 1
Group Appearance index 0.90

Latest deals

CompanyIndustryRound SizeDateInvestorsLocation

VerImmune

Biotechnology
Therapeutics
$4M23 Sep 2024 Baltimore, Maryland, United States

Rapafusyn Pharmaceuticals

$28M20 Jun 2024 Baltimore, Maryland, United States

VerImmune

Biotechnology
Therapeutics
$3M20 Sep 2023 Baltimore, Maryland, United States

Immune-Onc Therapeutics

Biopharma
Biotechnology
Health Care
Medical
Therapeutics
$25M05 Jan 2023 Palo Alto, California, United States

VerImmune

Biotechnology
Therapeutics
$2M27 Jul 2022 Baltimore, Maryland, United States

Yidianling

Psychology
$30M22 Dec 2021 Shanghai, China

Great Bay Bio

Biopharma
Biotechnology
Life Science
$10M01 Dec 2021 Hong Kong Island, Hong Kong, China

Bioelectronica

Biotechnology
Electronics
Health Diagnostics
08 Feb 2021 Reno, Nevada, United States

Singlera Genomics

Biotechnology
Genetics
Health Care
Health Diagnostics
Medical
$150M15 Dec 2020 San Diego, California, United States
Crunchbase icon

Content report

The following text will be sent to our editors: